iSpecimen Inc., a company specializing in biosample procurement, is evaluating investment proposals from various cryptocurrency firms as part of its $200 million treasury plan. The company is actively pursuing an initiative using Solana (SOL) for this purpose. This involves purchasing SOL through over-the-counter transactions, including acquiring locked SOL with transfer restrictions. 💰 🔐 🏛️ 💻 Robert Lim, CEO of iSpecimen Inc., acknowledged the appeal of investing in locked SOL, but the company is continuing to explore other avenues. iSpecimen plans to adopt a buy-and-hold strategy for its crypto treasury, utilizing regular fundraising efforts and potentially staking SOL to generate returns.